Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles

Science Advances

Volumn 4, Issue 3, 2018, Pages

  Ricklefs, Franz L ^a,b   Alayo, Quazim ^a   Krenzlin, Harald ^a   Mahmoud, Ahmad B ^a,c   Speranza, Maria C ^a,d   Nakashima, Hiroshi ^a   Hayes, Josie L ^e   Lee, Kyungheon ^f   Balaj, Leonora ^f   Passaro, Carmela ^a   Rooj, Arun K ^a   Krasemann, Susanne ^b   Carter, Bob S ^f   Chen, Clark C ^g   Steed, Tyler ^g   Treiber, Jeffrey ^g   Rodig, Scott ^a   Yang, Katherine ^a   Nakano, Ichiro ^h   Lee, Hakho ^f   Weissleder, Ralph ^f   Breakefield, Xandra O ^f   Godlewski, Jakub ^a   Westphal, Manfred ^b   Lamszus, Katrin ^b   Freeman, Gordon J ^d   Bronisz, Agnieszka ^a   Lawler, Sean E ^a,i   Chiocca, E Antonio ^a,j   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c TAIBAH UNIVERSITY   (Saudi Arabia)

^d HARVARD MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j BAYLOR COLLEGE OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BINS; CELL DEATH; CELL MEMBRANES; CELLS; CHEMICAL ACTIVATION; CYTOLOGY; DISEASES; TUMORS;

ANTITUMOR IMMUNITY; CELL FUNCTIONS; EXTRACELLULAR; PROGRAMMED CELL DEATHS; T CELL ACTIVATION; T CELL RECEPTOR; TRANSCRIPTOME PROFILES; TUMOR PROGRESSIONS;

T-CELLS;

CD274 PROTEIN, HUMAN; GAMMA INTERFERON; LYMPHOCYTE ANTIGEN RECEPTOR; PROGRAMMED DEATH 1 LIGAND 1; TUMOR ANTIGEN;

BRAIN TUMOR; CANCER STEM CELL; EXOSOME; GENE EXPRESSION REGULATION; GENETICS; GLIOBLASTOMA; HUMAN; IMMUNE EVASION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; PATHOLOGY; T LYMPHOCYTE; TUMOR CELL LINE; UPREGULATION;

ANTIGENS, NEOPLASM; B7-H1 ANTIGEN; BRAIN NEOPLASMS; CELL LINE, TUMOR; EXTRACELLULAR VESICLES; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; IMMUNE EVASION; INTERFERON-GAMMA; LYMPHOCYTE ACTIVATION; NEOPLASTIC STEM CELLS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; UP-REGULATION;

EID: 85044122671     PISSN: None     EISSN: 23752548     Source Type: Journal    
DOI: 10.1126/sciadv.aar2766     Document Type: Article

References (40)

1. R. Stupp, W. P. Mason, M. J. van den Bent, M. Weller, B. Fisher, M. J. B. Taphoorn, K. Belanger, A. A. Brandes, C. Marosi, U. Bogdahn, J. Curschmann, R. C. Janzer, S. K. Ludwin, T. Gorlia, A. Allgeier, D. Lacombe, J. G. Cairncross, E. Eisenhauer, R. O. Mirimanoff; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group, Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996 (2005).
2. D. A. Reardon, G. Freeman, C. Wu, E. A. Chiocca, K. W. Wucherpfennig, P. Y. Wen, E. F. Fritsch, W. T. Curry Jr., J. H. Sampson, G. Dranoff, Immunotherapy advances for glioblastoma. Neuro Oncol. 16, 1441-1458 (2014).
3. D. M. Pardoll, The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252-264 (2012).
4. K. M. Mahoney, P. D. Rennert, G. J. Freeman, Combination cancer immunotherapy and new immunomodulatory targets. Nat. Rev. Drug Discov. 14, 561-584 (2015).
5. J. Kmiecik, A. Poli, N. H. C. Brons, A. Waha, G. E. Eide, P. Ø. Enger, J. Zimmer, M. Chekenya, Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. J. Neuroimmunol. 264, 71-83 (2013).
6. F. S. Hodi, S. J. O'Day, D. F. McDermott, R. W. Weber, J. A. Sosman, J. B. Haanen, R. Gonzalez, C. Robert, D. Schadendorf, J. C. Hassel, W. Akerley, A. J. M. van den Eertwegh, J. Lutzky, P. Lorigan, J. M. Vaubel, G. P. Linette, D. Hogg, C. H. Ottensmeier, C. Lebbé, C. Peschel, I. Quirt, J. I. Clark, J. D. Wolchok, J. S. Weber, J. Tian, M. J. Yellin, G. M. Nichol, A. Hoos, W. J. Urba, Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363, 711-723 (2010).
7. J. Larkin, F. S. Hodi, J. D. Wolchok, Combined nivolumab and ipilimumab or monotherapy in untreated melanoma. N. Engl. J. Med. 373, 1270-1271 (2015).
8. R. J. Motzer, B. Escudier, D. F. McDermott, S. George, H. J. Hammers, S. Srinivas, S. S. Tykodi, J. A. Sosman, G. Procopio, E. R. Plimack, D. Castellano, T. K. Choueiri, H. Gurney, F. Donskov, P. Bono, J. Wagstaff, T. C. Gauler, T. Ueda, Y. Tomita, F. A. Schutz, C. Kollmannsberger, J. Larkin, A. Ravaud, J. S. Simon, L.-A. Xu, I. M. Waxman, P. Sharma; CheckMate 025 Investigators, Nivolumab versus everolimus in advanced renal-cell carcinoma. N. Engl. J. Med. 373, 1803-1813 (2015).
9. G. J. Freeman, A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, H. F. Horton, L. Fouser, L. Carter, V. Ling, M. R. Bowman, B. M. Carreno, M. Collins, C. R. Wood, T. Honjo, Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J. Exp. Med. 192, 1027-1034 (2000).
10. M. E. Keir, S. C. Liang, I. Guleria, Y. E. Latchman, A. Qipo, L. A. Albacker, M. Koulmanda, G. J. Freeman, M. H. Sayegh, A. H. Sharpe, Tissue expression of PD-L1 mediates peripheral T cell tolerance. J. Exp. Med. 203, 883-895 (2006).
11. A. P. Patel, I. Tirosh, J. J. Trombetta, A. K. Shalek, S. M. Gillespie, H. Wakimoto, D. P. Cahill, B. V. Nahed, W. T. Curry, R. L. Martuza, D. N. Louis, O. Rozenblatt-Rosen, M. L. Suvà, A. Regev, B. E. Bernstein, Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344, 1396-1401 (2014).
12. T. Doucette, G. Rao, A. Rao, L. Shen, K. Aldape, J. Wei, K. Dziurzynski, M. Gilbert, A. B. Heimberger, Immune heterogeneity of glioblastoma subtypes: Extrapolation from the cancer genome atlas. Cancer Immunol. Res. 1, 112-122 (2013).
13. F. Ricklefs, M. Mineo, A. K. Rooj, I. Nakano, A. Charest, R. Weissleder, X. O. Breakefield, E. A. Chiocca, J. Godlewski, A. Bronisz, Extracellular vesicles from high-grade glioma exchange diverse pro-oncogenic signals that maintain intratumoral heterogeneity. Cancer Res. 76, 2876-2881 (2016).
14. A. Bronisz, Y. Wang, M. O. Nowicki, P. Peruzzi, K. I. Ansari, D. Ogawa, L. Balaj, G. De Rienzo, M. Mineo, I. Nakano, M. C. Ostrowski, F. Hochberg, R. Weissleder, S. E. Lawler, E. A. Chiocca, J. Godlewski, Extracellular vesicles modulate the glioblastoma microenvironment via a tumor suppression signaling network directed by miR-1. Cancer Res. 74, 738-750 (2014).
15. J. Skog, T. Würdinger, S. van Rijn, D. H. Meijer, L. Gainche, W. T. Curry Jr., B. S. Carter, A. M. Krichevsky, X. O. Breakefield, Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat. Cell Biol. 10, 1470-1476 (2008).
16. A. Clayton, J. P. Mitchell, J. Court, M. D. Mason, Z. Tabi, Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res. 67, 7458-7466 (2007).
17. E. K. Nduom, J. Wei, N. K. Yaghi, N. Huang, L.-Y. Kong, K. Gabrusiewicz, X. Ling, S. Zhou, C. Ivan, J. Q. Chen, J. K. Burks, G. N. Fuller, G. A. Calin, C. A. Conrad, C. Creasy, K. Ritthipichai, L. Radvanyi, A. B. Heimberger, PD-L1 expression and prognostic impact in glioblastoma. Neuro Oncol. 18, 195-205 (2016).
18. P. E. Simms, T. M. Ellis, Utility of flow cytometric detection of CD69 expression as a rapid method for determining poly- and oligoclonal lymphocyte activation. Clin. Diagn. Lab. Immunol. 3, 301-304 (1996).
19. M. Motamedi, L. Xu, S. Elahi, Correlation of transferrin receptor (CD71) with Ki67 expression on stimulated human and mouse T cells: The kinetics of expression of T cell activation markers. J. Immunol. Methods 437, 43-52 (2016).
20. C. P. Lai, E. Y. Kim, C. E. Badr, R. Weissleder, T. R. Mempel, B. A. Tannous, X. O. Breakefield, Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters. Nat. Commun. 6, 7029 (2015).
21. M. Shi, M. G. Roemer, B. Chapuy, X. Liao, H. Sun, G. S. Pinkus, M. A. Shipp, G. J. Freeman, S. J. Rodig, Expression of programmed cell death 1 ligand 2 (PD-L2) is a distinguishing feature of primary mediastinal (thymic) large B-cell lymphoma and associated with PDCD1LG2 copy gain. Am. J. Surg. Pathol. 38, 1715-1723 (2014).
22. B. B. Avants, N. J. Tustison, M. Stauffer, G. Song, B. Wu, J. C. Gee, The Insight ToolKit image registration framework. Front. Neuroinform. 8, 44 (2014).
23. Cancer Genome Atlas Research Network, Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455, 1061-1068 (2008).
24. O. Celiku, S. Johnson, S. Zhao, K. Camphausen, U. Shankavaram, Visualizing molecular profiles of glioblastoma with GBM-BioDP. PLOS ONE 9, e101239 (2014).
25. A. Krämer, J. Green, J. Pollard Jr., S. Tugendreich, Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523-530 (2014).
26. K. E. van der Vos, E. R. Abels, X. Zhang, C. Lai, E. Carrizosa, D. Oakley, S. Prabhakar, O. Mardini, M. H. W. Crommentuijn, J. Skog, A. M. Krichevsky, A. Stemmer-Rachamimov, T. R. Mempel, J. El Khoury, S. E. Hickman, X. O. Breakefield, Directly visualized glioblastoma-derived extracellular vesicles transfer RNA to microglia/macrophages in the brain. Neuro Oncol. 18, 58-69 (2016).
27. J. Godlewski, R. Ferrer-Luna, A. K. Rooj, M. Mineo, F. Ricklefs, Y. S. Takeda, M. O. Nowicki, E. Salińska, I. Nakano, H. Lee, R. Weissleder, R. Beroukhim, E. A. Chiocca, A. Bronisz, MicroRNA signatures and molecular subtypes of glioblastoma: The role of extracellular transfer. Stem Cell Rep. 8, 1497-1505 (2017).
28. M. Szajnik, M. Czystowska, M. J. Szczepanski, M. Mandapathil, T. L. Whiteside, Tumorderived microvesicles induce, expand and up-regulate biological activities of human regulatory T cells (Treg). PLOS ONE 5, e11469 (2010).
29. E. U. Wieckowski, C. Visus, M. Szajnik, M. J. Szczepanski, W. J. Storkus, T. L. Whiteside, Tumor-derived microvesicles promote regulatory T cell expansion and induce apoptosis in tumor-reactive activated CD8+ T lymphocytes. J. Immunol. 183, 3720-3730 (2009).
30. J. W. Kim, E. Wieckowski, D. D. Taylor, T. E. Reichert, S. Watkins, T. L. Whiteside, Fas ligand- positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes. Clin. Cancer Res. 11, 1010-1020 (2005).
31. L. Muller, M. Mitsuhashi, P. Simms, W. E. Gooding, T. L. Whiteside, Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Sci. Rep. 6, 20254 (2016).
32. O. Bloch, C. A. Crane, R. Kaur, M. Safaee, M. J. Rutkowski, A. T. Parsa, Gliomas promote immunosuppression through induction of B7-H1 expression in tumor-associated macrophages. Clin. Cancer Res. 19, 3165-3175 (2013).
33. J.-A. Cho, D.-J. Yeo, H.-Y. Son, H.-W. Kim, D.-S. Jung, J.-K. Ko, J. S. Koh, Y.-N. Kim, C.-W. Kim, Exosomes: A new delivery system for tumor antigens in cancer immunotherapy. Int. J. Cancer 114, 613-622 (2005).
34. J. B. Iorgulescu, M. E. Ivan, M. Safaee, A. T. Parsa, The limited capacity of malignant glioma-derived exosomes to suppress peripheral immune effectors. J. Neuroimmunol. 290, 103-108 (2016).
35. J. E. Hellwinkel, J. S. Redzic, T. A. Harland, D. Gunaydin, T. J. Anchordoquy, M. W. Graner, Glioma-derived extracellular vesicles selectively suppress immune responses. Neuro Oncol. 18, 497-506 (2016).
36. G. Berchem, M. Z. Noman, M. Bosseler, J. Paggetti, S. Baconnais, E. Le Cam, A. Nanbakhsh, E. Moussay, F. Mami-Chouaib, B. Janji, S. Chouaib, Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-b and miR23a transfer. Oncoimmunology 5, e1062968 (2016).
37. M. Lundholm, M. Schröder, O. Nagaeva, V. Baranov, A. Widmark, L. Mincheva-Nilsson, P. Wikström, Prostate tumor-derived exosomes down-regulate NKG2D expression on natural killer cells and CD8+ T cells: Mechanism of immune evasion. PLOS ONE 9, e108925 (2014).
38. T. C. Steed, J. M. Treiber, K. S. Patel, Z. Taich, N. S. White, M. L. Treiber, N. Farid, B. S. Carter, A. M. Dale, C. C. Chen, Iterative probabilistic voxel labeling: Automated segmentation for analysis of the Cancer Imaging Archive glioblastoma images. AJNR Am. J. Neuroradiol. 36, 678-685 (2015).
39. M. Ceccarelli, F. P. Barthel, T. M. Malta, T. S. Sabedot, S. R. Salama, B. A. Murray, O. Morozova, Y. Newton, A. Radenbaugh, S. M. Pagnotta, S. Anjum, J. Wang, P. Zoppoli, S. Ling, A. A. Rao, M. Grifford, A. D. Cherniack, H. Zhang, L. Poisson, C. G. Carlotti Jr., D. P. da Cunha Tirapelli, A. Rao, T. Mikkelsen, C. C. Lau, W. K. A. Yung, R. Rabadan, J. Huse, D. J. Brat, N. L. Lehman, J. S. Barnholtz-Sloan, S. Zheng, K. Hess, G. Rao, M. Meyerson, R. Beroukhim, L. Cooper, R. Akbani, M. Wrensch, D. Haussler, K. D. Aldape, P. W. Laird, D. H. Gutmann, TCGA Research Network, H. Noushmehr, A. Iavarone, R. G. W. Verhaak, Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma. Cell 164, 550-563 (2016).
40. M. J. Hawrylycz, E. S. Lein, A. L. Guillozet-Bongaarts, E. H. Shen, L. Ng, J. A. Miller, L. N. van de Lagemaat, K. A. Smith, A. Ebbert, Z. L. Riley, C. Abajian, C. F. Beckmann, A. Bernard, D. Bertagnolli, A. F. Boe, P. M. Cartagena, M. M. Chakravarty, M. Chapin, J. Chong, R. A. Dalley, B. D. Daly, C. Dang, S. Datta, N. Dee, T. A. Dolbeare, V. Faber, D. Feng, D. R. Fowler, J. Goldy, B. W. Gregor, Z. Haradon, D. R. Haynor, J. G. Hohmann, S. Horvath, R. E. Howard, A. Jeromin, J. M. Jochim, M. Kinnunen, C. Lau, E. T. Lazarz, C. Lee, T. A. Lemon, L. Li, Y. Li, J. A. Morris, C. C. Overly, P. D. Parker, S. E. Parry, M. Reding, J. J. Royall, J. Schulkin, P. A. Sequeira, C. R. Slaughterbeck, S. C. Smith, A. J. Sodt, S. M. Sunkin, B. E. Swanson, M. P. Vawter, D. Williams, P. Wohnoutka, H. R. Zielke, D. H. Geschwind, P. R. Hof, S. M. Smith, C. Koch, S. G. N. Grant, A. R. Jones, An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 489, 391-399 (2012).